ClinicalTrials.gg
CompletedNCT04670848Updated Jan 25, 2022

Contactless Detection of Sleep Apnea

An interventional study of Sleepiz One+ vs. polysomnography in Sleep Apnea, sponsored by Sleepiz AG. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-25.

Sponsored by Sleepiz AG · Not applicable, Interventional, and Diagnostic

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 58 studies in Sleep Apnea Syndromes with a site in Germany — 4 open to participants now, 4 under way, none of them phase 3. Sleep Apnea Syndromes · Germany.

Enrollment
11th of 29
116 · median 60
Started
2020
with 1 other
No phase
21 of 58
none open now
Registered
53rd of 58
by date

Among the 58 studies in Sleep Apnea Syndromes with a site in Germany, this one is the 11th largest by enrollment of the 29 interventional ones that give a count, is one of 2 that started in 2020, is one of 21 with no phase, and was the 53rd registered.

Sleep Apnea Syndromes

1,085 studies on the registry are indexed under Sleep Apnea Syndromes; 172 are open to participants now.

Browse Sleep Apnea Syndromes studies →

Open to participants now

4 of the 58 studies in Sleep Apnea Syndromes with a site in Germany are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 119 Sleep Apnea Syndromes studies recruiting now, 58 (49%) set no upper age limit and 37 (31%) stop at 75 or younger; 25 take children under 18; 28 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 58 studies in Sleep Apnea Syndromes with a site in Germany, or all of them as a file.
02

Study summary

In this study the inestigators aim to validate the performance of Sleepiz One+ for sleep apnea detection during routine diagnostic sleep studies. Patients who are prescribed polysomnography study will be asked to participate and undergo a simultaneous sleep recording with radar sensor-based device.

03

Conditions studied

  • Sleep Apnea
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >18years
  • Ability and consent to undergo electrophysiological routine assessment
  • Patients suspected to suffer from sleep apnea or any other sleep related disorder

Exclusion criteria

Exclusion Criteria:

  • Previous enrollment into the current study,
  • Enrollment of the investigator, his/her family members and other dependent persons
  • Cardiac pacemaker or another implanted electrical device
  • Women who are pregnant or breastfeeding
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
116 participants (actual)

Study arms

  • Experimental
    Patients suspected of suffering from sleep apnea

    Device: Sleepiz One+ vs. polysomnography

  • Experimental
    Healthy volunteers

    Device: Sleepiz One+ vs. polysomnography

Interventions

  • DeviceSleepiz One+ vs. polysomnography

    Simultaneous sleep recording with polysomnography and Sleepiz One+ device

06

What researchers measure

Primary outcomes

  1. Binary classification of subjects based on their sleep apnea severity (AHI ≥= 15) made by Sleepiz One+, compared to PSG data manually scored by sleep technicians

    Time frame: 1 Night

07

Study locations

1 site
  • Universitätsmedizin Essen Ruhrlandklinik
    Essen, North Rhine-Westphalia 45239, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2020 to primary completion in Dec 2021, 12 months.

Of 69 industry-sponsored interventional studies with no phase under Sleep Apnea Syndromes, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 18. This study's 12 months is close to that.

Counting every sponsor, half of 271 studies reached it within 26 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2020
First posted
Dec 17, 2020
StartActual
Dec 7, 2020
Primary completionActual
Dec 21, 2021
CompletionActual
Dec 21, 2021
Last update
Jan 25, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04670848
Lead sponsor
Sleepiz AG
Responsible party
Sponsor
First posted
Dec 17, 2020
Start date
Dec 7, 2020
Primary completion
Dec 21, 2021
Completion
Dec 21, 2021
Last update
Jan 25, 2022

Study contacts

Christoph Schöbel, Prof. Dr. med.
principal investigator · Universitätsmedizin Essen Ruhrlandklinik

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion